Building upon our prior findings that BSTJF ameliorates PCOS via Sirtuin 3 mediated mitochondrial oxidative stress regulation [16], this study delineates its therapeutic action through NADPH oxidase-dependent redox dysregulation. The gene discussed is SIRT3; the disease is polycystic ovary syndrome.